05-Oct-2007 - An ingredient in chillies could form the basis of a new pain management formulation without creating numbness, researchers in the US have found.
04-Oct-2007 - The era of human polyclonal antibodies has dawned as efforts get underway to produce the next generation therapeutics in transgenic chickens.
04-Oct-2007 - FMC BioPolymer has been forced to raise the price of its pharmaceutical grade cellulose by up to eight per cent to meet market pressures.
04-Oct-2007 - The US Food and Drug Administration (FDA) has sent a letter to Genzyme to warn it about manufacturing issues at its biomanufacturing facility in Lyon, France.
03-Oct-2007 - SAFC has announced its plans to build a new high potency conjugation suite at its Missouri manufacturing plant in order to target pharma clients developing novel anti-cancer drug conjugates.
03-Oct-2007 - Mylan, Momenta Pharmaceuticals, VaxGen, Osprey Pharmaceuticals, Bioject Medical Technologies, and Othera Pharmaceuticals have all had people on the move in the world of pharmaceutical manufacturing.
03-Oct-2007 - US regulators have found a new 'hundreds and thousands'-like drug treatment to be very palatable.
02-Oct-2007 - The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials.
02-Oct-2007 - Discovery Laboratories could see the end of its struggle to launch its Surfaxin (lucinactant) drug on the US market as it has finally resolved the manufacturing issues that have plagued the product for months.
01-Oct-2007 - DSM has announced the conclusions for the company's complete overhaul as it accelerates the shift to a life sciences and materials sciences company.
01-Oct-2007 - Novartis's potential Type II diabetes blockbuster has been given the green light in the EU after receiving approval.
27-Sep-2007 - An extended release formulation of an asthma treatment recently recommended by the National Asthma Education and Prevention Program has been launched on the US market.
27-Sep-2007 - Organon subsidiary Nobilon has got its hands on a promising new adjuvant that it plans to use to enhance it pandemic and seasonal flu vaccines.
27-Sep-2007 - Contract manufacturer SAFC is investing $29m (€21m) to expand its Jerusalem, Israel manufacturing capacity for high-potency biologics.
26-Sep-2007 - Emergent BioSolutions and Elusys Therapeutics have been granted US contracts each for the development of anthrax therapeutics.
25-Sep-2007 - Following the recent news that pharma heavyweight Pfizer has also been struck by contamination of its HIV drug Viracept (nelfinavir), in-PharmaTechnologist.com spoke to the US Food and Drug Administration (FDA) to find out how far reaching the consequences of this latest contamination case could be.
25-Sep-2007 - European regulators have recommended that Roche's marketing authorisation for HIV drug Viracept (nelfinavir) be reinstated, following serious good manufacturing practice (GMP) deviations that caused toxic contamination of drug batches distributed to up to 25,000 patients.
25-Sep-2007 - GlaxoSmithKline (GSK) has been granted EU approval of its adjuvanted cervical cancer vaccine Cervarix, and is confident that the jab can challenge the likes of Merck's high-profile Gardasil.
20-Sep-2007 - Roche has just had the child-size, lower strength version of its blockbuster flu treatment Tamiflu (oseltamivir) approved by EU authorities, though possibly just a little too late for this year's flu season.
20-Sep-2007 - SkyePharma is looking towards a positive future despite a pre-tax operating loss of £14.1m (€20.3m), announced in the UK company's unaudited six-month results.
19-Sep-2007 - Two US pharmaceutical companies have joined forces to develop new prescription adult cough products using an oral drug delivery technology.
19-Sep-2007 - French processing and synthesis specialist Groupe Novasep is heading to the sun with the acquisition of Bahamas-based ingredients and intermediates firm PharmaChem Technologies.
19-Sep-2007 - Almost 700 jobs are to be lost at Belgian firm Janssen Pharmaceutica, as the Johnson and Johnson subsidiary falls victim to a restructuring drive at its parent company.
18-Sep-2007 - Sontra Medical has announced its intention to merge with Echo Therapeutics in a bid to create a company with a powerful transdermal drug delivery offering, and steadying Sontra's rickety financial position.
18-Sep-2007 - UK researchers are developing 'green' methods of coating delicate biopharmaceutical drugs that reduce the risk of damaging the drugs while replacing the harsh solvents normally used in the process.